{"id":108766,"date":"2026-07-16T14:37:39","date_gmt":"2026-07-16T12:37:39","guid":{"rendered":"https:\/\/www.ipsen.com\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/"},"modified":"2026-07-16T14:38:26","modified_gmt":"2026-07-16T12:38:26","slug":"une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement","status":"publish","type":"lay_language","link":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/","title":{"rendered":"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial"},"content":{"rendered":"<p class=\"heading-para wp-block-paragraph\">Cabozantinib<\/p>","protected":false},"excerpt":{"rendered":"<p>Cabozantinib<\/p>\n","protected":false},"author":11,"template":"","lay_language_category":[80958],"class_list":["post-108766","lay_language","type-lay_language","status-publish","hentry","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global\" \/>\n<meta property=\"og:description\" content=\"Cabozantinib\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/\" \/>\n<meta property=\"og:site_name\" content=\"Global\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-16T12:38:26+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ipsengroup\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/lay-language\\\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/lay-language\\\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\\\/\",\"name\":\"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\"},\"datePublished\":\"2026-07-16T12:37:39+00:00\",\"dateModified\":\"2026-07-16T12:38:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/lay-language\\\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/lay-language\\\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/lay-language\\\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"name\":\"Global\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#organization\",\"name\":\"IPSEN\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"contentUrl\":\"https:\\\/\\\/www.ipsen.com\\\/wp-content\\\/uploads\\\/2023\\\/12\\\/Latest_Ipsen-logo_168x48.svg\",\"caption\":\"IPSEN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.ipsen.com\\\/fr\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Ipsengroup\",\"https:\\\/\\\/x.com\\\/ipsengroup\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/","og_locale":"fr_FR","og_type":"article","og_title":"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global","og_description":"Cabozantinib","og_url":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/","og_site_name":"Global","article_modified_time":"2026-07-16T12:38:26+00:00","twitter_card":"summary_large_image","twitter_site":"@ipsengroup","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/","url":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/","name":"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial - Global","isPartOf":{"@id":"https:\/\/www.ipsen.com\/fr\/#website"},"datePublished":"2026-07-16T12:37:39+00:00","dateModified":"2026-07-16T12:38:26+00:00","breadcrumb":{"@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.ipsen.com\/fr\/lay-language\/une-etude-sur-le-cabozantinib-chez-des-personnes-atteintes-dun-cancer-du-rein-de-stade-avance-qui-na-pas-pu-etre-traite-par-chirurgie-et-qui-sest-aggrave-apres-un-traitement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.ipsen.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Une \u00e9tude sur le cabozantinib chez des personnes atteintes d\u2019un cancer du rein de stade avanc\u00e9 qui n\u2019a pas pu \u00eatre trait\u00e9 par chirurgie et qui s\u2019est aggrav\u00e9 apr\u00e8s un traitement initial"}]},{"@type":"WebSite","@id":"https:\/\/www.ipsen.com\/fr\/#website","url":"https:\/\/www.ipsen.com\/fr\/","name":"Global","description":"","publisher":{"@id":"https:\/\/www.ipsen.com\/fr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.ipsen.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.ipsen.com\/fr\/#organization","name":"IPSEN","url":"https:\/\/www.ipsen.com\/fr\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/","url":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","contentUrl":"https:\/\/www.ipsen.com\/wp-content\/uploads\/2023\/12\/Latest_Ipsen-logo_168x48.svg","caption":"IPSEN"},"image":{"@id":"https:\/\/www.ipsen.com\/fr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/Ipsengroup","https:\/\/x.com\/ipsengroup"]}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/108766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language"}],"about":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/types\/lay_language"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/users\/11"}],"version-history":[{"count":1,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/108766\/revisions"}],"predecessor-version":[{"id":108767,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language\/108766\/revisions\/108767"}],"wp:attachment":[{"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/media?parent=108766"}],"wp:term":[{"taxonomy":"lay_language_category","embeddable":true,"href":"https:\/\/www.ipsen.com\/fr\/wp-json\/wp\/v2\/lay_language_category?post=108766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}